Moderna Prepares Broader Mflusiva Launch for 2027–2028 Season
Moderna says it is preparing a broader commercial launch of Mflusiva during the 2027–2028 respiratory season, following U.S. and Canadian approvals in 2026.
Moderna says it is preparing a broader commercial launch of Mflusiva during the 2027–2028 respiratory season, following U.S. and Canadian approvals in 2026.